Carrier Screening: Linda Hasadsri, M.D., Ph.D.
Linda Hasadsri, M.D., Ph.D., explains Mayo Clinic Laboratories' new carrier screening panels. The panels use targeted genotyping to evaluate genes associated with cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and hemoglobinopathies, which
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(01:11)
Dr. Hasadsri, could you provide us with an overview of what carrier screening is?
(02:28)
Can you really expand on why these tests are important?
(05:25)
So in your experience, who could benefit from carrier screening and when should that testing be performed?
(06:45)
Can you just share how does a healthcare provider order carrier screening and then secondarily what sample types are accepted?
(08:05)
Can you share what are some of the unique features of our testing that sets the Mayo Clinic Laboratories apart?
(10:36)
So the last question I have is could you just summarize the benefits of doing carrier screening at Mayo?